Professional Documents
Culture Documents
Research Report, Dark Horse & IPO Info From Smart Investments
Research Report, Dark Horse & IPO Info From Smart Investments
care services. The company offers its products in various therapeutic classes,
such as antifungal, antibiotics, anticancer, anti-diabetic, antidepressant, anti-
ulcerant, antimalarial, anti-inflammatory, analgesic, antispasmodic, anti-tuber-
culosis, cardiovascular, dermatological, non-steroidal anti-inflammatory drugs,
psychotropic, trichology, and vitamins and minerals.
BDH has an equity base of Rs.5.94 crore that is supported by reserves of
around Rs.37.13 crore. The promoters hold 49.73% of the equity capital, which
leaves 50.27% stake for the investing public.
For Q4FY21, BDH posted a 60.87% higher PAT of Rs.1.85 crore on 62.45%
higher sales of Rs.20.29 crore and an EPS of Rs.3.22. It declared 30% divi-
dend for FY21. Currently, the stock trades at a P/E of just 13.8x.
Company can be Re Rated in future if company decide to shift plant at other
industrial area and sell land of kandivali as it has prime land in Kandivali East
adjoining Big Bazar.
Investors can accumulate this stock with a stop loss of Rs.125. It may
give very good returns in medium to long term.
Cont...
Financial Weekly
diversified customer base including Original Equipment Manufacturers ("OEM") and Tier-1 cus-
tomers in the Commercial Vehicle, Tractor, Railways and Off-Highway Vehicle segments spread
across India, Europe, North America and Southeast Asia. Company is a trusted partner and a
strategic supplier with long-standing strategic relationships with TAFE, Tata Motors, Ashok Leyland,
Volvo-Eicher Commercial Vehicles, Same Deutz-Fahr India, Daimler, Automotive Axles, Dana,
American Axles & Manufacturing, Comer Industries, Meritor, Wabtec, ZF.
It has an equity base of Rs.17.40 crore that is supported by reserves of around Rs.412.69 crore
which is almost 23 times higher against equity. The promoters hold 74.87%, while the investing
public holds 25.13% stake in the company.
For Q4FY21, NELCAST posted PAT of Rs.6.64 crore on 75.70% higher sales of Rs.220.45
crore and an EPS of Rs.0.76. During Q4FY21, its operating profit grew 43.52% to Rs.18.50 crore
as against Rs.12.89 crore in Q4FY20. During Q4FY21 company paid tax of 2.76 crore while during
Q4FY20 company got tax credit of 11.24 crore. Due to this we have seen Q4FY21 profits at lower
levels. Company paid 10% dividend for FY20.
Investors can accumulate this stock with a stop loss of Rs.83. It may give very good returns in
medium to long term. Cont...
Financial Weekly
(Seller)
Devyani Intl. 86 to 90 54 to 56 -- --
Nuvoco Vistas --
CarTrade --